{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:17:09Z","timestamp":1791353829826,"version":"4.3.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03560-w","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T10:08:44Z","timestamp":1740564524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Middle lobe tumors and lymphovascular invasion as independent predictors of recurrence-free survival in stage I NSCLC"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6986-2651","authenticated-orcid":false,"given":"Mustafa","family":"Aky\u0131l","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6037-7278","authenticated-orcid":false,"given":"Serkan","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"3560_CR1","volume-title":". SEER cancer statistics review 1975\u20132017","author":"N Howlader","year":"2020","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, et al. SEER cancer statistics review 1975\u20132017. Bethesda, MD: National Cancer Institute; 2020."},{"issue":"13","key":"3560_CR2","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","volume":"28","author":"A Aup\u00e9rin","year":"2010","unstructured":"Aup\u00e9rin A, Le P\u00e9choux C, Rolland E, Curran WJ, Furuse K, Fournel P, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol. 2010;28(13):2181\u201390.","journal-title":"J Clin Oncol"},{"key":"3560_CR3","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.3390\/cancers16091710","volume":"16","author":"WK Kuo","year":"2024","unstructured":"Kuo WK, Chen PJ, Wu MH, Lee HC, Fan JK, Hsu PH, et al. Tumor Location is an independent prognostic factor in completely resected pathological stage I non-small cell lung Cancer: a Multicenter Retrospective Study. Cancers. 2024;16:9: 1710.","journal-title":"Cancers"},{"key":"3560_CR4","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/1759-7714.12869","volume":"9","author":"HW Lee","year":"2018","unstructured":"Lee HW, Lee CH, Park YS. Location of stage I-III non-small cell lung cancer and survival rate: systematic review and meta-analysis. Thorac Cancer. 2018;9:1614\u201322.","journal-title":"Thorac Cancer"},{"key":"3560_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF01624531","volume":"12","author":"M Riquet","year":"1990","unstructured":"Riquet M, Dupont P, Hidden G, Debesse B. Lymphatic drainage of the middle lobe of the adult lung. Surg Radiol Anat. 1990;12:231\u20133.","journal-title":"Surg Radiol Anat"},{"issue":"5","key":"3560_CR6","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.athoracsur.2017.12.007","volume":"105","author":"Y Handa","year":"2018","unstructured":"Handa Y, Tsutani Y, Ikeda T, Hanaki H, Miyata Y, Mukaida H, et al. Reassessment of right middle lobe Lung Cancer: comparison of segments 4 and 5 tumors. Ann Thorac Surg. 2018;105(5):1543\u201350.","journal-title":"Ann Thorac Surg"},{"key":"3560_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000488859","volume":"95","author":"SY Sung","year":"2018","unstructured":"Sung SY, Kwak YK, Lee SW, Jo IY, Park JK, Kim KS, et al. Lymphovascular invasion increases the risk of nodal and distant recurrence in node-negative stage I-IIA non-small-cell lung cancer. Oncology. 2018;95:156\u201362.","journal-title":"Oncology"},{"key":"3560_CR8","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1093\/ejcts\/ezt309","volume":"44","author":"N Yanagawa","year":"2013","unstructured":"Yanagawa N, Shiono S, Abiko M, Ogata SY, Sato T, Tamura G. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma. Eur J Cardiothorac Surg. 2013;44:e200\u20136.","journal-title":"Eur J Cardiothorac Surg"},{"key":"3560_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.lungcan.2021.08.017","volume":"161","author":"A De Giglio","year":"2021","unstructured":"De Giglio A, Di Federico A, Gelsomino F, Ardizzoni A. Prognostic relevance of pleural invasion for resected NSCLC patients undergoing adjuvant treatments: a propensity score-matched analysis of SEER database. Lung Cancer. 2021;161:18\u201325.","journal-title":"Lung Cancer"},{"key":"3560_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39\u201351.","journal-title":"J Thorac Oncol"},{"key":"3560_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"18","key":"3560_CR12","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.3390\/cancers13184705","volume":"13","author":"O Rodak","year":"2021","unstructured":"Rodak O, Peris-D\u00edaz MD, Olbromski M, Podhorska-Oko\u0142\u00f3w M, Dzi\u0119giel P. Current landscape of non-small cell lung cancer: epidemiology, histological classification, targeted therapies, and immunotherapy. Cancers (Basel). 2021;13(18):4705.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"3560_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.21037\/atm.2016.03.11","volume":"4","author":"J Didkowska","year":"2016","unstructured":"Didkowska J, Wojciechowska U, Ma\u0144czuk M, \u0141obaszewski J. Lung cancer epidemiology: contemporary and future challenges worldwide. Ann Transl Med. 2016;4(8):150.","journal-title":"Ann Transl Med"},{"issue":"17","key":"3560_CR14","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1056\/NEJMoa060476","volume":"355","author":"CI Henschke","year":"2006","unstructured":"Henschke CI, Yankelevitz DF, International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355(17):1763\u201371.","journal-title":"N Engl J Med"},{"key":"3560_CR15","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jtcvs.2014.02.064","volume":"148","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Sun Y, Xiang J, Zhang Y, Hu H, Chen H. A clinicopathologic prediction model for postoperative recurrence in stage Ia non-small cell lung cancer. J Thorac Cardiovasc Surg. 2014;148:1193\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3560_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jss.2012.05.022","volume":"177","author":"BA Whitson","year":"2012","unstructured":"Whitson BA, Groth SS, Andrade RS, Habermann EB, Maddaus MA, D\u2019Cunha J. T1\/T2 non-small-cell lung cancer treated by lobectomy: does tumor anatomic location matter? J Surg Res. 2012;177:185\u201390.","journal-title":"J Surg Res"},{"key":"3560_CR17","first-page":"e117","volume":"48","author":"F Mazza","year":"2015","unstructured":"Mazza F, Ferrari E, Maineri P, Venturino M, Dozin B, Ratto GB. Pulmonary middle lobectomy for non-small-cell lung cancer: effectiveness and prognostic implications. Eur J Cardiothorac Surg. 2015;48:e117\u201323.","journal-title":"Eur J Cardiothorac Surg"},{"key":"3560_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.athoracsur.2013.10.048","volume":"97","author":"C Rivera","year":"2014","unstructured":"Rivera C, Mordant P, Pricopi C, Arame A, Foucault C, Dujon A, et al. Is the rate of pneumonectomy higher in right middle lobe lung cancer than in other right-sided locations? Ann Thorac Surg. 2014;97:402\u20137.","journal-title":"Ann Thorac Surg"},{"key":"3560_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0169-5002(96)00553-3","volume":"14","author":"H Miura","year":"1996","unstructured":"Miura H, Kato H, Konaka C, Usuda J, Uchida O, Taira O. Primary lung cancer of the middle lobe. Is its prognosis poor? Lung Cancer. 1996;14:273\u20139.","journal-title":"Lung Cancer"},{"key":"3560_CR20","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/1759-7714.12782","volume":"9","author":"X Lv","year":"2018","unstructured":"Lv X, Cao J, Dai X, Rusidanmu A. Survival rates after lobectomy versus sublobar resection for early-stage right middle lobe non-small cell lung cancer. Thorac Cancer. 2018;9:1026\u201331.","journal-title":"Thorac Cancer"},{"key":"3560_CR21","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.21037\/jtd.2019.05.48","volume":"11","author":"G Lin","year":"2019","unstructured":"Lin G, Liu H, Li J. Lobectomy versus sub-lobar resection in patients with stage IA right middle lobe non-small cell lung cancer: a propensity score matched analysis. J Thorac Dis. 2019;11:2523\u201334.","journal-title":"J Thorac Dis"},{"key":"3560_CR22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1513\/AnnalsATS.201305-127OC","volume":"10","author":"RR Veluswamy","year":"2013","unstructured":"Veluswamy RR, Mhango G, Bonomi M, Neugut AI, Hershman DL, Aldridge MD, et al. Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection. Ann Am Thorac Soc. 2013;10:622\u20138.","journal-title":"Ann Am Thorac Soc"},{"key":"3560_CR23","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.athoracsur.2013.11.002","volume":"97","author":"NM Mollberg","year":"2014","unstructured":"Mollberg NM, Bennette C, Howell E, Backhus L, Devine B, Ferguson MK. Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-small Cell Lung Cancer: a systematic review and Meta-analysis. Ann Thorac Surg. 2014;97:965\u201371.","journal-title":"Ann Thorac Surg"},{"key":"3560_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1378\/chest.09-3046","volume":"138","author":"R Maeda","year":"2010","unstructured":"Maeda R, Yoshida J, Ishii G, Hishida T, Aokage K, Nishimura M, et al. Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3\u00a0cm in maximum dimension. Chest. 2010;138:357\u201362.","journal-title":"Chest"},{"key":"3560_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.athoracsur.2010.11.038","volume":"91","author":"MJ Schuchert","year":"2011","unstructured":"Schuchert MJ, Schumacher L, Kilic A, Close J, Landreneau JR, Pennathur A, et al. Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I non-small cell lung cancer. Ann Thorac Surg. 2011;91:1059\u201365.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"3560_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.lungcan.2012.04.002","volume":"77","author":"T Kato","year":"2012","unstructured":"Kato T, Ishikawa K, Aragaki M, Sato M, Okamoto K, Ishibashi T, et al. Angiolymphatic invasion exerts a strong impact on surgical outcomes for stage I lung adenocarcinoma, but not non-adenocarcinoma. Lung Cancer. 2012;77(2):394\u2013400.","journal-title":"Lung Cancer"},{"key":"3560_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.lungcan.2018.09.024","volume":"125","author":"S Wang","year":"2018","unstructured":"Wang S, Zhang B, Qian J, Qiao R, Xu J, Zhang L, et al. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer. Lung Cancer. 2018;125:245\u201352.","journal-title":"Lung Cancer"},{"key":"3560_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/00015458.2023.2231210","volume":"124","author":"TI Akcam","year":"2024","unstructured":"Akcam TI, Tekneci AK, Ergin TM, Memmedov R, Ergonul AG, Ozdil A, et al. Factors influencing postoperative recurrence of early-stage non-small cell lung cancer. Acta Chir Belg. 2024;124:121\u201330.","journal-title":"Acta Chir Belg"},{"key":"3560_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/icvts\/ivv287","volume":"22","author":"JP Akshay","year":"2016","unstructured":"Akshay JP, Gwion Daniel B, Naidu, Ehab Bishay. The significance of microvascular invasion after complete resection of early-stage non-small-cell lung cancer. Interact Cardiovasc Thorac Surg. 2016;22:101\u20135.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"3560_CR30","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.lungcan.2007.01.019","volume":"56","author":"T Tsuchiya","year":"2007","unstructured":"Tsuchiya T, Akamine S, Muraoka M, Kamohara R, Tsuji K, Urabe S, et al. Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung Cancer. 2007;56:341\u20138.","journal-title":"Lung Cancer"},{"key":"3560_CR31","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1111\/1759-7714.14530","volume":"13","author":"JS Cai","year":"2022","unstructured":"Cai JS, Wang X, Yang F, Li Y, Qiu MT. Lymphovascular invasion: a non-sized T descriptor for stage IA non-small cell lung cancer. Thorac Cancer. 2022;13:2413\u201320.","journal-title":"Thorac Cancer"},{"key":"3560_CR32","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/JTO.0000000000000559","volume":"10","author":"R Rami-Porta","year":"2015","unstructured":"Rami-Porta R, Bolejack V, Crowley J, Ball D, Kim J, Lyons G, et al. The IASLC Lung Cancer Staging Project: proposals for the revisions of the T descriptors in the Forthcoming Eighth Edition of the TNM classification for Lung Cancer. J Thorac Oncol. 2015;10:990\u20131003.","journal-title":"J Thorac Oncol"},{"key":"3560_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cllc.2017.06.001","volume":"19","author":"D Noma","year":"2018","unstructured":"Noma D, Inamura K, Matsuura Y, Hirata Y, Nakajima T, Yamazaki H, et al. Prognostic effect of lymphovascular invasion on TNM staging in stage I non-small-cell lung cancer. Clin Lung Cancer. 2018;19:109\u201322.","journal-title":"Clin Lung Cancer"},{"key":"3560_CR34","unstructured":"National Comprehensive Cancer Network, Non-Small Cell Lung Cancer. (Version 4.2021). https:\/\/www.nccn.org\/professionals\/physician__gls\/pdf\/nscl.pdf (accessed March 5, 2021)."},{"issue":"9","key":"3560_CR35","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","volume":"7","author":"JY Douillard","year":"2006","unstructured":"Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonz\u00e1les-Larriba JL, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol. 2006;7(9):719\u201327.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3560_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3904\/kjim.2020.011","volume":"37","author":"J Choi","year":"2022","unstructured":"Choi J, Oh JY, Lee YS, Min KH, Shim JJ, Choi SI, et al. Clinical efficacy of adjuvant chemotherapy in stage IB (<\u20094\u00a0cm) non-small cell lung cancer patients with high-risk factors. Korean J Intern Med. 2022;37(1):127.","journal-title":"Korean J Intern Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03560-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03560-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03560-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T10:08:48Z","timestamp":1740564528000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03560-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3560"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03560-w","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the S\u00fcreyyapa\u015fa Chest Disease and Thoracic Surgery Training and Research Hospital Ethics Committee (2024-21\/01.08.2024). Due to the retrospective nature of the study, the obligation to obtain informed consent was waived by the Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}